Abstract
Thymopentin (TP5) is an effective immunomodulatory agent for autoimmune disease that has been used clinically for decades. However, its application is greatly limited by its extremely short half-life in vivo, poor membrane permeability and extensive metabolism in gastrointestinal tract, resulting in repeated injection and poor patient compliance. In the present study, we developed a TP5-loaded, phospholipid-based phase separation gel (PPSG) to achieve sustained drug release profile and long-lasting therapeutic effects. We firstly demonstrated the physiochemical characteristics of PPSG before and after phase transition by examining the viscosity and morphology change caused by the phase transition. Moreover, the PPSG exerted a low cytotoxicity in L929 cells and HUVECs, suggesting the biocompatibility of PPSG. A month-long drug release profile of TP5 PPSG was observed both in vitro and in vivo, revealing its sustained and controlled drug release property. Most importantly, in cyclophosphamide-induced immunosuppressive rats, a single dose of TP5 PPSG (15 mg/kg, sc) injected could normalize their T-SOD levels and CD4+/CD8+ ratio; such an immunoregulatory effect was comparable to that produced by repeated injection of TP5 solution (...Continue Reading
References
Jan 1, 1979·International Journal of Peptide and Protein Research·J P TischioG Goldstein
Nov 1, 1983·International Journal of Peptide and Protein Research·T Audhya, G Goldstein
Jun 25, 1998·Immunologic Research·V K SinghS S Agarwal
Aug 12, 1999·Pharmaceutica acta Helvetiae·S GonserG Folkers
Oct 30, 1999·Human Gene Therapy·A SauerbreyJ R Bertino
Feb 26, 2000·International Journal of Immunopharmacology·B BodeyH E Kaiser
May 16, 2000·European Journal of Clinical Investigation·A TreitingerD S Abdalla
Jul 18, 2001·Journal of the American Chemical Society·B A SimmonsR Moore
Nov 14, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yashu YinHaiyang Hu
Aug 31, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·YaShu YinHaiYang Hu
Jul 14, 2010·Pharmaceutical Research·Yan-Zhen LiZhi-Rong Zhang
Aug 3, 2010·International Journal of Pharmaceutics·Gang WeiWeiyue Lu
Nov 25, 2011·Biomaterials·Qiang PengXun Sun
Sep 13, 2013·Journal of Biomolecular Structure & Dynamics·Maxim S KondratyevElena G Novoselova
Mar 20, 2014·Molecular Pharmaceutics·Chengyu WuXun Sun
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Min-Hyo KiDae-Duk Kim
Jan 13, 2015·Experimental Cell Research·Ming-Xia ZhuXiao-Yan Ke
Feb 11, 2015·Biomaterials·Ting ZhangZhi-Rong Zhang
Mar 13, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fatemeh RavarFarid A Dorkoosh
Apr 5, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mengxin WangTao Gong
Oct 19, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shiqi LinChuanbin Wu
Citations
Dec 20, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hamed AmaniHélder A Santos
Apr 21, 2021·Advanced Materials·Shukun LiXuehai Yan
Jul 7, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Rui YuCongmei Chen
Jun 15, 2021·Frontiers in Immunology·Xubiao WeiYucui Tong
Jul 13, 2021·Advanced Materials·Mahshid KharazihaNasim Annabi